与外用1%克林霉素抗生素溶液相比，用可见蓝光治疗面部轻至中度炎性寻常痤疮的多中心临床评估。
A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
作者信息
Gold Michael H, Rao Jaggi, Goldman Mitchel P, Bridges Tancy M, Bradshaw Virginia L, Boring Molly M, Guider April N
机构信息
Gold Skin Care Center, Tennessee Clinical Research Center Nashville, TN 37215, USA.
出版信息
J Drugs Dermatol. 2005 Jan-Feb;4(1):64-70.
BACKGROUND
Blue light sources have been shown to be effective in the treatment of mild to moderate inflammatory acne vulgaris lesions.
OBJECTIVE
We evaluated the safety and efficacy of a new blue light source in the treatment of mild to moderate inflammatory acne vulgaris in comparison to topical 1% clindamycin solution.
RESULTS
Blue light therapy reduced inflammatory acne vulgaris lesions by an average of 34%, as compared to 14% for topical 1% clindamycin solution.
CONCLUSIONS
The blue light source presented in this report is a safe and effective treatment option available to our patients with mild to moderate inflammatory acne lesions.
背景
蓝光光源已被证明在治疗轻至中度炎性寻常痤疮皮损方面有效。
目的
我们评估了一种新型蓝光光源与外用1%克林霉素溶液相比，在治疗轻至中度炎性寻常痤疮方面的安全性和有效性。
结果
蓝光疗法使炎性寻常痤疮皮损平均减少34%，而外用1%克林霉素溶液使皮损减少14%。
结论
本报告中呈现的蓝光光源是我们患有轻至中度炎性痤疮皮损患者可采用的一种安全有效的治疗选择。
Zotero 插件